Altomare John F MD is categorized under Internal Medicine Doctors in Reading, PA and active since 2011.
Altomare John F MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Altomare at the company’s single location by writing to 301 South 7th Avenue # 215, Reading, Pennsylvania PA 19611 or by phoning (610) 374-4401. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Altomare John F MD |
| Contact Person: | John Altomare |
| Address: | 301 South 7th Avenue # 215, Reading, Pennsylvania 19611 |
| Phone Number: | (610) 374-4401 |
| Website Address: | dda-berks.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Altomare John F MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Altomare for inquiries that concern Altomare John F MD by calling the company number (610) 374-4401, as your correspondence is most welcome. Additionally, the physical location of the single location of Altomare John F MD can be found at the coordinates 40.33063,-75.95216 as well as the street address 301 South 7th Avenue # 215 in Reading, Pennsylvania 19611.
For its online presence, you may visit Altomare John F MD’s website at dda-berks.com and engage with its social media outlets through on Twitter and on Facebook.